Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03844672 · ClinicalTrials.gov registry record · NA
Impact of E-cigarette Characteristics on Reinforcement and Tobacco Use Patterns
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT03844672: Completed NA study, sponsored by Medical University of South Carolina.
NCT03844672 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 93 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03844672, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
The purpose of this project is to understand how different e-cigarettes influence their likeability and use among current smokers who try using e-cigarettes. Participants will receive an e-cigarette to sample over a three week period. During this time period they will complete daily electronic diaries and weekly lab visits. The results from this information will help understand how different types of e-cigarettes are likely to influence cigarette and e-cigarette use.
Primary Outcome
Participants complete weekly surveys reporting the number of cigarettes smoked each day on a continuous scale
Interventions
- BEHAVIORAL Low Power
- BEHAVIORAL High Power
- BEHAVIORAL Low Concentration
- BEHAVIORAL High Concentration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2023-11-09 |
| Phase | NA |
What the finished NCT03844672 record still lists
NCT03844672 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 4 interventions - of which Low Power is the first listed.
NCT03844672 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03844672 about?
NCT03844672 is a clinical study titled "Impact of E-cigarette Characteristics on Reinforcement and Tobacco Use Patterns". The purpose of this project is to understand how different e-cigarettes influence their likeability and use among current smokers who try using e-cigarettes. Participants will receive an e-cigarette to sample over a three week period. During this time period they will complete daily electronic diari...
What is the current status of trial NCT03844672?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2019-04-01. Estimated completion is 2023-11-09.
What interventions are being tested in trial NCT03844672?
The interventions under investigation include: Low Power (BEHAVIORAL), High Power (BEHAVIORAL), Low Concentration (BEHAVIORAL), High Concentration (BEHAVIORAL).
Who is sponsoring clinical trial NCT03844672?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03844672's enrollment target sits among peer trials
93 937th of 2000 higher than 1,064 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI